Principal Financial Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.69M Buy
188,196
+171,701
+1,041% +$1.54M ﹤0.01% 1823
2025
Q1
$124K Sell
16,495
-1,312
-7% -$9.84K ﹤0.01% 2087
2024
Q4
$134K Sell
17,807
-393,607
-96% -$2.96M ﹤0.01% 2133
2024
Q3
$3.13M Buy
411,414
+375,890
+1,058% +$2.86M ﹤0.01% 1692
2024
Q2
$220K Sell
35,524
-12,691
-26% -$78.4K ﹤0.01% 2125
2024
Q1
$245K Buy
48,215
+216
+0.5% +$1.1K ﹤0.01% 2137
2023
Q4
$288K Sell
47,999
-679
-1% -$4.07K ﹤0.01% 2075
2023
Q3
$345K Buy
48,678
+1,120
+2% +$7.93K ﹤0.01% 2024
2023
Q2
$335K Buy
47,558
+353
+0.7% +$2.49K ﹤0.01% 2047
2023
Q1
$394K Buy
47,205
+384
+0.8% +$3.2K ﹤0.01% 2028
2022
Q4
$538K Sell
46,821
-55,845
-54% -$641K ﹤0.01% 1960
2022
Q3
$1.29M Sell
102,666
-96,743
-49% -$1.22M ﹤0.01% 1797
2022
Q2
$2.11M Buy
199,409
+162,417
+439% +$1.72M ﹤0.01% 1790
2022
Q1
$601K Sell
36,992
-1,509
-4% -$24.5K ﹤0.01% 2078
2021
Q4
$534K Sell
38,501
-15,012
-28% -$208K ﹤0.01% 2106
2021
Q3
$769K Sell
53,513
-8,571
-14% -$123K ﹤0.01% 2068
2021
Q2
$981K Sell
62,084
-10,657
-15% -$168K ﹤0.01% 2045
2021
Q1
$740K Sell
72,741
-2,039
-3% -$20.7K ﹤0.01% 2057
2020
Q4
$557K Buy
74,780
+19,816
+36% +$148K ﹤0.01% 2086
2020
Q3
$189K Sell
54,964
-1,734
-3% -$5.96K ﹤0.01% 2216
2020
Q2
$270K Buy
56,698
+23,824
+72% +$113K ﹤0.01% 2110
2020
Q1
$66K Buy
32,874
+1,409
+4% +$2.83K ﹤0.01% 2144
2019
Q4
$109K Sell
31,465
-1,679
-5% -$5.82K ﹤0.01% 2182
2019
Q3
$95K Buy
33,144
+3,391
+11% +$9.72K ﹤0.01% 2182
2019
Q2
$113K Sell
29,753
-1,284
-4% -$4.88K ﹤0.01% 2174
2019
Q1
$253K Buy
31,037
+857
+3% +$6.99K ﹤0.01% 2078
2018
Q4
$244K Buy
30,180
+12,400
+70% +$100K ﹤0.01% 2083
2018
Q3
$136K Sell
17,780
-11,180
-39% -$85.5K ﹤0.01% 2210
2018
Q2
$166K Buy
28,960
+1,482
+5% +$8.5K ﹤0.01% 2182
2018
Q1
$131K Buy
27,478
+2,285
+9% +$10.9K ﹤0.01% 2140
2017
Q4
$124K Buy
25,193
+13,154
+109% +$64.7K ﹤0.01% 2172
2017
Q3
$63K Sell
12,039
-2,336
-16% -$12.2K ﹤0.01% 2161
2017
Q2
$80K Buy
14,375
+1,125
+8% +$6.26K ﹤0.01% 2206
2017
Q1
$111K Buy
13,250
+45
+0.3% +$377 ﹤0.01% 2138
2016
Q4
$84K Hold
13,205
﹤0.01% 2172
2016
Q3
$58K Buy
13,205
+566
+4% +$2.49K ﹤0.01% 2132
2016
Q2
$36K Hold
12,639
﹤0.01% 2144
2016
Q1
$36K Buy
12,639
+322
+3% +$917 ﹤0.01% 2135
2015
Q4
$127K Hold
12,317
﹤0.01% 2092
2015
Q3
$140K Buy
12,317
+2,247
+22% +$25.5K ﹤0.01% 2074
2015
Q2
$150K Sell
10,070
-6,407
-39% -$95.4K ﹤0.01% 2085
2015
Q1
$149K Sell
16,477
-2,879
-15% -$26K ﹤0.01% 2060
2014
Q4
$235K Buy
19,356
+789
+4% +$9.58K ﹤0.01% 2001
2014
Q3
$182K Buy
18,567
+2,271
+14% +$22.3K ﹤0.01% 2050
2014
Q2
$208K Buy
+16,296
New +$208K ﹤0.01% 2075